Eli Lilly and Company LLY | NYSE

$794.10 -$104.85 | -11.66%

After Hours
$813.48 $19.38 | 2.44%

Company Overview:

Market Cap: $752.80B
PE Ratio: 64.51
52-Week Range: $677.09 - $972.53
Dividend Yield (FWD): 0.76% ($6.00)

10 Year Performance Metrics:

Total Return (with DRIP): 1,203.43% (29.27% / yr)
Total Return (no DRIP): 1,030.80% (27.45% / yr)
Share Price: 987.06%
Dividend Increase: 200.00
LLY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

LLY Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
Share Price
LLY Price CAGR:1Y: 2.23%2Y: 39.89%5Y: 38.89%10Y: 26.94%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

LLY Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - LLY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - LLY
14-Day FREE Trial Get Full Access Now!

LLY Earnings, Revenue, Cash & Debt, Shares Outstaning:

LLY - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
LLY - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
LLY - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
LLY - Cash & Debt
14-Day FREE Trial Get Full Access Now!
LLY - Revenue
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 44.68%2Y: 36.14%5Y: 17.22%10Y: 10.20%
LLY - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
LLY EPS CAGR:1Y: 111.26%2Y: 54.67%5Y: 25.62%10Y: 28.75%
LLY - Net Income
14-Day FREE Trial Get Full Access Now!
LLY Net Income CAGR:1Y: 101.39%2Y: 50.86%5Y: 24.14%10Y: 26.25%
LLY - EBITDA
14-Day FREE Trial Get Full Access Now!
LLY EBITDA CAGR:1Y: 102.62%2Y: 60.30%5Y: 29.27%10Y: 16.04%
LLY - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow CAGR:1Y: 137.01%2Y: -15.77%5Y: -15.00%10Y: -2.02%
LLY - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow / Share CAGR:1Y: 138.89%2Y: -13.63%5Y: -14.79%10Y: -0.39%
LLY - Gross Profit
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit CAGR:1Y: 44.64%2Y: 39.08%5Y: 18.16%10Y: 11.15%
LLY - Expenses
14-Day FREE Trial Get Full Access Now!
LLY Expenses CAGR:1Y: 5.82%2Y: 77.33%5Y: 39.86%10Y: 14.30%
LLY - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
LLY Shares Outstanding CAGR:1Y: -4.87%2Y: -2.51%5Y: -1.16%10Y: -2.05%
LLY - Share Buybacks
14-Day FREE Trial Get Full Access Now!
LLY Share Buybacks CAGR:1Y: 173.85%2Y: 0.00%5Y: 46.92%10Y: 21.21%
LLY - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
LLY Stock-Based Comp CAGR:1Y: 18.05%2Y: 23.59%5Y: 11.70%10Y: 13.33%
LLY - Dividends
14-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.38%2Y: 15.21%5Y: 15.18%10Y: 11.61%
LLY - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 44.68%2Y: 36.14%5Y: 17.22%10Y: 10.20%
LLY - Revenue by Region
14-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 44.68%2Y: 36.14%5Y: 17.22%10Y: 10.20%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LLY - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Revenue CAGR:1Y: 44.68%2Y: 36.14%5Y: 17.22%10Y: 10.20%
LLY - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EPS CAGR:1Y: 111.26%2Y: 54.67%5Y: 25.62%10Y: 28.75%
LLY - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual Net Income CAGR:1Y: 101.39%2Y: 50.86%5Y: 24.14%10Y: 26.25%
LLY - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
LLY Actual EBITDA CAGR:1Y: 102.62%2Y: 60.30%5Y: 29.27%10Y: 16.04%

Ratios, Profit Margins & Return on Capital:

LLY - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Net Profit Margin CAGR:1Y: 39.21%2Y: 10.81%5Y: 5.91%10Y: 14.56%
LLY - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
LLY Gross Profit Margin CAGR:1Y: -0.02%2Y: 2.16%5Y: 0.80%10Y: 0.85%
LLY - Price to Earnings
14-Day FREE Trial Get Full Access Now!
LLY - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
LLY - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
LLY - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!
Compare stocks side-by-side
 

LLY Dividends Info:

Annual Dividend: $6.00
Forward Yield: 0.76%
Ex-Dividend Date: 2025-02-14
Lifetime Dividens / Share: $66.25

LLY Dividend History: Dates, Payments & Yield list

Below is a schedule of all LLY dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/14/202503/10/2025$1.5000.64%0.71%$844.27
11/15/202412/10/2024$1.3000.7%0.7%$746.20
08/15/202409/10/2024$1.3000.54%0.56%$931.58
05/15/202406/10/2024$1.3000.62%0.66%$787.02
02/14/202403/08/2024$1.3000.62%0.69%$757.31
11/14/202312/08/2023$1.1300.74%0.74%$610.82
08/14/202309/08/2023$1.1300.81%0.84%$538.00
05/12/202306/09/2023$1.1300.97%1.04%$434.43
02/14/202303/10/2023$1.1301.17%1.3%$347.56
11/14/202212/09/2022$0.9801.1%1.1%$356.06
08/12/202209/09/2022$0.9801.23%1.27%$308.08
05/13/202206/10/2022$0.9801.26%1.34%$291.63
02/14/202203/10/2022$0.9801.5%1.67%$234.69
11/12/202112/10/2021$0.8501.31%1.31%$259.65
08/12/202109/10/2021$0.8501.25%1.29%$263.47
05/13/202106/10/2021$0.8501.63%1.74%$194.94
02/11/202103/10/2021$0.8501.52%1.68%$202.58
11/12/202012/10/2020$0.7402.1%2.1%$141.03
08/13/202009/10/2020$0.7401.9%1.97%$150.46
05/14/202006/10/2020$0.7401.75%1.87%$158.38
02/13/202003/10/2020$0.7401.89%2.09%$141.80
11/14/201912/10/2019$0.6452.32%2.32%$111.39
08/14/201909/10/2019$0.6452.26%2.34%$110.29
05/16/201906/10/2019$0.6452.07%2.21%$116.73
02/14/201903/08/2019$0.6451.93%2.14%$120.75
11/14/201812/10/2018$0.5632.05%2.05%$109.81
08/14/201809/10/2018$0.5632.15%2.2%$102.44
05/16/201806/08/2018$0.5632.67%2.77%$81.18
02/14/201803/09/2018$0.5632.76%2.92%$77.03
11/14/201712/08/2017$0.5202.52%2.52%$82.49
08/11/201709/08/2017$0.5202.55%2.56%$81.15
05/11/201706/09/2017$0.5202.57%2.59%$80.22
02/13/201703/10/2017$0.5202.64%2.67%$77.77
11/10/201612/09/2016$0.5102.6%2.6%$78.34
08/11/201609/09/2016$0.5102.52%2.53%$80.56
05/11/201606/10/2016$0.5102.65%2.67%$76.31
02/10/201603/10/2016$0.5102.75%2.79%$73.07
11/10/201512/10/2015$0.5002.5%2.5%$80.06
08/12/201509/10/2015$0.5002.39%2.4%$83.38
05/14/201506/10/2015$0.5002.71%2.74%$73.06
02/11/201503/10/2015$0.5002.82%2.86%$69.95
11/12/201412/10/2014$0.4902.91%2.91%$67.40
08/13/201409/10/2014$0.4903.23%3.23%$60.59
05/13/201406/10/2014$0.4903.26%3.26%$60.04
02/12/201403/10/2014$0.4903.68%3.68%$53.32
11/13/201312/10/2013$0.4903.88%3.88%$50.55
08/13/201309/10/2013$0.4903.57%3.57%$54.96
05/14/201306/10/2013$0.4903.51%3.51%$55.87
02/13/201303/08/2013$0.4903.67%3.67%$53.44
11/13/201212/10/2012$0.4904.16%4.16%$47.14
08/13/201209/10/2012$0.4904.58%4.58%$42.81
05/11/201206/08/2012$0.4904.75%4.75%$41.26
02/13/201203/09/2012$0.4905.05%5.05%$38.85
11/10/201112/09/2011$0.4905.26%5.26%$37.23
08/11/201109/09/2011$0.4905.55%5.55%$35.30
05/11/201106/10/2011$0.4905.12%5.12%$38.28
02/11/201103/10/2011$0.4905.68%5.68%$34.52
11/10/201012/10/2010$0.4905.6%5.6%$34.99
08/11/201009/10/2010$0.4905.34%5.34%$36.71
05/12/201006/10/2010$0.4905.64%5.64%$34.78
02/10/201003/10/2010$0.4905.74%5.74%$34.17
11/10/200912/10/2009$0.4905.56%5.56%$35.25
08/12/200909/10/2009$0.4905.89%5.95%$32.94
05/13/200906/10/2009$0.4905.46%5.58%$35.15
02/11/200903/10/2009$0.4905.17%5.34%$36.72
11/12/200812/10/2008$0.4705.88%5.88%$31.99
08/13/200809/10/2008$0.4703.79%3.89%$48.38
05/13/200806/10/2008$0.4703.76%3.95%$47.55
02/13/200803/10/2008$0.4703.47%3.73%$50.34
11/13/200712/10/2007$0.4253.23%3.23%$52.64
08/13/200709/10/2007$0.4252.94%2.99%$56.93
05/11/200706/08/2007$0.4252.82%2.91%$58.43
02/13/200703/09/2007$0.4252.99%3.13%$54.28
11/13/200612/08/2006$0.4002.96%2.96%$54.06
08/11/200609/08/2006$0.4002.91%2.94%$54.36
05/11/200606/09/2006$0.4003.05%3.13%$51.12
02/13/200603/10/2006$0.4002.78%2.89%$55.35
11/10/200512/09/2005$0.3802.96%2.96%$51.40
08/11/200509/09/2005$0.3802.79%2.83%$53.64
05/11/200506/10/2005$0.3802.5%2.59%$58.75
02/11/200503/10/2005$0.3802.6%2.74%$55.50
11/10/200412/10/2004$0.3552.55%2.55%$55.62
08/11/200409/10/2004$0.3552.24%2.27%$62.60
05/12/200406/10/2004$0.3551.87%1.93%$73.71
02/11/200403/10/2004$0.3551.82%1.9%$74.70
11/12/200312/10/2003$0.3352.02%2.02%$66.19
08/13/200309/10/2003$0.3352.11%2.15%$62.20
05/13/200306/10/2003$0.3352.02%2.1%$63.80
02/12/200303/10/2003$0.3352.15%2.28%$58.89
11/13/200212/10/2002$0.3102.06%2.06%$60.29
08/13/200209/10/2002$0.3102.16%2.21%$56.00
05/13/200206/10/2002$0.3101.83%1.92%$64.58
02/13/200203/08/2002$0.3101.51%1.63%$76.12
11/13/200112/10/2001$0.2801.42%1.42%$78.97
08/13/200109/10/2001$0.2801.4%1.43%$78.46
05/11/200106/11/2001$0.2801.29%1.33%$83.90
02/13/200103/09/2001$0.2801.33%1.4%$79.99
11/13/200012/11/2000$0.2601.21%1.21%$86.13
08/11/200009/11/2000$0.2601.31%1.35%$77.00
05/11/200006/09/2000$0.2601.31%1.39%$74.88
02/11/200003/10/2000$0.2601.54%1.69%$61.63
11/10/199912/10/1999$0.2301.21%1.21%$75.94
08/11/199909/10/1999$0.2301.45%1.5%$61.50
05/12/199906/10/1999$0.2301.13%1.2%$76.44
02/10/199903/10/1999$0.2300.95%1.05%$87.38
11/10/199812/10/1998$0.2000.93%0.93%$85.63
08/12/199809/10/1998$0.2001.17%1.17%$68.63
05/13/199806/10/1998$0.2001.14%1.17%$68.63
02/11/199803/10/1998$0.2001.15%1.21%$66.13
11/12/199712/10/1997$0.2001.17%1.27%$63.13
08/13/199709/10/1997$0.1801.36%1.38%$52.25
05/13/199706/10/1997$0.1801.51%1.55%$46.44
02/12/199703/10/1997$0.1801.53%1.59%$45.25
11/13/199612/10/1996$0.1711.81%1.81%$37.81
08/13/199609/10/1996$0.1712.32%2.32%$29.50
05/13/199606/10/1996$0.1712.42%2.45%$27.94
02/13/199603/11/1996$0.1712.07%2.14%$32.06
11/13/199512/11/1995$0.1712.72%2.84%$24.09
08/11/199509/11/1995$0.1613.37%3.4%$18.97
05/09/199506/12/1995$0.1613.47%3.52%$18.31
02/09/199503/10/1995$0.1613.84%3.93%$16.41
11/08/199412/12/1994$0.1563.96%3.96%$15.78
08/09/199409/12/1994$0.1565.09%5.13%$12.19
05/09/199406/10/1994$0.1564.63%4.71%$13.28
02/09/199403/10/1994$0.1564.22%4.33%$14.44
11/08/199312/10/1993$0.1514.34%4.34%$13.94
08/09/199309/10/1993$0.1515.33%5.46%$11.09
05/10/199306/10/1993$0.1514.55%4.77%$12.69
02/09/199303/10/1993$0.1514.15%4.45%$13.59
11/06/199212/10/1992$0.1383.59%3.59%$15.34
08/10/199209/10/1992$0.1383.08%3.15%$17.44
05/11/199206/10/1992$0.1383.12%3.27%$16.84
02/10/199203/10/1992$0.1382.59%2.78%$19.81
11/08/199112/10/1991$0.1252.63%2.63%$19.03
08/09/199109/10/1991$0.1252.41%2.52%$19.84
05/09/199106/10/1991$0.1252.36%2.6%$19.25
02/07/199103/11/1991$0.1252.34%2.71%$18.47
11/08/199012/10/1990$0.1032.39%2.39%$17.13
08/09/199009/10/1990$0.1032.01%2.1%$19.50
05/09/199006/11/1990$0.1032.17%2.38%$17.25
02/09/199003/12/1990$0.1032.26%2.61%$15.69
11/09/198912/11/1989$0.0842.11%2.11%$16.00
08/09/198909/11/1989$0.0842.12%2.2%$15.34
05/09/198906/12/1989$0.0842.37%2.56%$13.16
02/09/198903/10/1989$0.0842.53%2.85%$11.86
11/08/198812/12/1988$0.0722.64%2.64%$10.89
08/09/198809/12/1988$0.0722.67%2.76%$10.42
05/09/198806/10/1988$0.0722.78%2.98%$9.66
02/09/198803/10/1988$0.0722.84%3.15%$9.13
11/06/198712/10/1987$0.0632.65%2.65%$9.42
08/10/198709/10/1987$0.0631.97%2.02%$12.38
05/11/198706/10/1987$0.0632.19%2.31%$10.83
02/09/198703/10/1987$0.0632.18%2.35%$10.63
11/07/198611/12/1986$0.0562.41%2.41%$9.33
08/11/198608/13/1986$0.0562.3%2.37%$9.50
05/09/198605/14/1986$0.0562.41%2.55%$8.83
02/10/198602/12/1986$0.0562.95%3.22%$6.98
11/08/198511/13/1985$0.0503.36%3.36%$5.95
08/09/198508/14/1985$0.0503.85%3.85%$5.19
05/09/198505/13/1985$0.0503.97%4.07%$4.92
02/08/198502/13/1985$0.0504.19%4.4%$4.55
11/08/198411/12/1984$0.0504.73%5.09%$3.93
08/09/198408/13/1984$0.0454.97%4.97%$3.65
05/09/198405/11/1984$0.0454.66%4.66%$3.89
02/08/198402/10/1984$0.0454.6%4.72%$3.84
11/07/198311/09/1983$0.0450%0%$0.00
08/09/198308/11/1983$0.0450%0%$0.00
05/09/198305/11/1983$0.0410%0%$0.00
02/09/198302/11/1983$0.0410%0%$0.00
11/05/198211/10/1982$0.0410%0%$0.00
08/09/198208/11/1982$0.0410%0%$0.00
05/10/198205/12/1982$0.0410%0%$0.00
02/08/198202/10/1982$0.0410%0%$0.00
11/06/198111/11/1981$0.0360%0%$0.00
08/10/198108/12/1981$0.0360%0%$0.00
05/11/198105/13/1981$0.0360%0%$0.00
02/05/198102/09/1981$0.0360%0%$0.00
11/07/198011/12/1980$0.0360%0%$0.00
08/11/198008/13/1980$0.0360%0%$0.00
05/12/198005/14/1980$0.0330%0%$0.00
02/08/198002/13/1980$0.0330%0%$0.00
11/02/197911/07/1979$0.0330%0%$0.00
08/06/197908/08/1979$0.0330%0%$0.00
05/07/197905/09/1979$0.0280%0%$0.00
02/05/197902/07/1979$0.0280%0%$0.00
11/03/197811/08/1978$0.0280%0%$0.00
08/07/197808/09/1978$0.0250%0%$0.00
05/08/197805/10/1978$0.0250%0%$0.00
02/06/197802/08/1978$0.0250%0%$0.00
11/03/197711/07/1977$0.0220%0%$0.00
08/08/197708/10/1977$0.0220%0%$0.00
05/09/197705/11/1977$0.0220%0%$0.00
02/04/197702/09/1977$0.0220%0%$0.00
11/05/197611/10/1976$0.0200%0%$0.00
08/09/197608/11/1976$0.0200%0%$0.00
05/10/197605/12/1976$0.0190%0%$0.00
02/06/197602/11/1976$0.0190%0%$0.00
11/07/197511/12/1975$0.0170%0%$0.00
08/11/197508/13/1975$0.0170%0%$0.00
05/12/197505/14/1975$0.0170%0%$0.00
02/07/197502/12/1975$0.0170%0%$0.00
11/08/197411/13/1974$0.0160%0%$0.00
08/12/197408/14/1974$0.0160%0%$0.00
05/13/197405/15/1974$0.0150%0%$0.00
02/08/197402/13/1974$0.0150%0%$0.00
11/12/197311/14/1973$0.0130%0%$0.00
08/13/197308/15/1973$0.0130%0%$0.00
05/14/197305/16/1973$0.0120%0%$0.00
02/09/197302/14/1973$0.0120%0%$0.00
11/13/197211/15/1972$0.0110%0%$0.00
08/07/197208/09/1972$0.0110%0%$0.00

Projected Future Returns & Dividends for LLY

Based on past 10-year performance, here are LLY growth metrics:

Share price CAGR of +26.94%
Dividend CAGR of +11.61%

Using LLY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

LLY (DRIP)LLY - No DRIP
Current Price$794.10$794.10
Start Shares12.5912.59
Start Value$10,000$10,000
  
After 10 years:
Final Share Count13.1812.59
Dividends Payment$4.50$4.50
Annual Dividends$237$227
Yield on cost2.37%2.27%
Share Price$6,794.07$6,794.07
Total Dividends$1,342$1,301
Final Value$89,519$86,858

Estimated Future Value + Dividends - LLY

NOTE: Above numbers are our estimate based on LLY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Eli Lilly and Company (LLY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

LLY website: https://www.lilly.com

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial